Ngā kupu hautoa kōpae

Tohutoro APA (7th ed.)
Joarder, R., Patel, D., Tiwari, A., Choudhary, J., Vana, P., Shenoy, V., . . . Ostwal, V. (2025). TAS-102 Plus Bevacizumab as an Effective and Well Tolerated Regimen in Chemotherapy-Refractory Advanced Colorectal Cancers – A Single Institution Retrospective Analysis. Thieme Medical and Scientific Publishers Pvt. Ltd.
Tohutoru Kātū Chicago (17th ed.)
Joarder, Ritam, et al. TAS-102 Plus Bevacizumab as an Effective and Well Tolerated Regimen in Chemotherapy-Refractory Advanced Colorectal Cancers – A Single Institution Retrospective Analysis. Thieme Medical and Scientific Publishers Pvt. Ltd, 2025.
Tohutoro MLA (9th ed.)
Joarder, Ritam, et al. TAS-102 Plus Bevacizumab as an Effective and Well Tolerated Regimen in Chemotherapy-Refractory Advanced Colorectal Cancers – A Single Institution Retrospective Analysis. Thieme Medical and Scientific Publishers Pvt. Ltd, 2025.
Kia tūpato: Kāore pea ēnei kupu hautoa i te ōrite pū 100%.